2021 Update
Clinical Research Currents has temporarily suspended publication.
Learn about our new clinical trials startup, Sparrow Search, connecting patients with clinical trials.
Verily, the life sciences company owned by Google parent Alphabet, has partnered with Novartis, Sanofi, Otsuka, and Pfizer on a project that aims to speed up clinical trials. The pharma companies will use Verily’s clinical research tools- known as Project Baseline – to try to improve the recruitment of patients into clinical trials and make studies faster and more efficient. (pharmaforum)
We recently interviewed Hakim Mohamed on the current challenges facing clinical research sites, and how the sites are responding. Mohamed is the Co-Founder and CEO of One Source Clinical Management (OSCM), with several clinical research sites. Prior to founding OSCM, Hakim served as Administrator and CFO with Synergy Clinical Research Read more
The University of California San Diego School of Medicine’s Center for Medicinal Cannabis Research is seeking participants for a set of clinical trials exploring the effectiveness of cannabidiol (CBD) and tetrahydrocannabinol (THC) in treating symptoms of severe autism, anorexia nervosa, essential tremor, and early psychosis. The studies are small, each recruiting fewer than 80 participants. (Candid Chronicle)
Is it fair to pay different participants in the same study different amounts of money– in reimbursement for costs incurred; compensation for time and burden; and incentives to participate? The authors argue that differential payment is ethically acceptable, but it could potentially create tension among clinical trial participants. (Journal of Medical Ethics)
— by John Neal The clinical research industry continued its rapid evolution during 2018, coming off of a year of major activity and changes in 2017. It is no time for the faint of heart, or those resistant to change. As I first predicted in 2016 in my “Change is Read more
1. Make the language reader-friendly. 2. Create the website for your target audience. 3. Provide relevant and informative details about the trial. And more. (Clinical Site Services)
www.appliedclinicaltrialsonline.com
A recent survey of 4,000 patients and care providers examined the patient perspective on clinical trials. The most important motivator to take part in a trial was safety- the clinical trial should do no harm. Institutional support from one’s physician was also important, as were health benefits– the potential to benefit their personal health. (Applied Clinical Trials)
The annual J.P. Morgan Healthcare Conference, a health care investment symposium, was held January 7-10, 2019 in San Francisco, with over 9,000 attendees. Numerous sessions discussed inefficiencies in clinical trials and how we can innovate to facilitate research and drug development without placing an undue burden on patients by trial participation requirements. (Healio Gastroenterology)
An innovative approach to collecting control group data in clinical trials called “synthetic control arms” means that, instead of collecting data from a newly-recruited control arm, synthetic control arms model those comparators using real-world data that has been previously collected. This approach reduces the number of participants needed for trials and eliminates participants’ fears that they will end up in a placebo group. (STAT)
Article by Guest Blogger Kathy Perez In this age of smart phones, cloud-based voice helpers and all things “Google” the public and medical profession have many ways to find a clinical trial. The most comprehensive listing of clinical trials in the world can be found at www.clinicaltrials.gov but when you Read more